Bruker: Attractive Valuation Ahead Of An Earnings Inflection
Source: SeekingAlpha
2026-01-09 06:07:23 ET
Investment Thesis
Read the full article on Seeking Alpha
For further details see:
Bruker: Attractive Valuation Ahead Of An Earnings Inflection
Bruker Corporation
NASDAQ: BRKR
BRKR Trading
2.71% G/L:
$34.685 Last:
128,928 Volume:
$34 Open:
BRKR Latest News
February 25, 2026 07:00:00 am
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
February 24, 2026 07:00:00 am
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
BRKR Stock Data
$6,342,783,056
108,941,800
0.01%
138
N/A
Biotechnology & Life Sciences
Healthcare
US
Billerica
